(Q42439060)

31 October 2017

Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function. (English)

1 reference

31 October 2017

1 reference

Siobhan Robinson

1

1 reference

31 October 2017

Pierre Freeman

2

1 reference

31 October 2017

Cynthia Moore

3

1 reference

31 October 2017

Justin C Touchon

4

1 reference

31 October 2017

Lisa Krentz

5

1 reference

31 October 2017

Charles K Meshul

6

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

31 October 2017

Experimental Neurology

1 reference

31 October 2017

180

1 reference

31 October 2017

1

1 reference

31 October 2017

74-87

1 reference

The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

GluR1 glutamate receptor subunit is regulated differentially in the primate basal ganglia following nigrostriatal dopamine denervation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

NMDA antagonists partially protect against MPTP induced neurotoxicity in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutamate and aspartate in the mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Impaired glutamate clearance as a consequence of energy failure caused by MPP(+) in astrocytic cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium-size spiny neurons in the rat neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

NMDA receptor blockade reverses motor response alterations induced by levodopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Synergistic interactions between NMDA-antagonists and L-dopa on activity in MPTP-treated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Role of presynaptic dopamine receptors in regulation of the glutamatergic neurotransmission in rat neostriatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Autoradiographic analysis of N-methyl-D-aspartate receptor binding in monkey brain: effects of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and levodopa treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Characterization of antisera to glutamate and aspartate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Modulatory Effect of Dopamine on High-Affinity Glutamate Uptake in the Rat Striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

MPTP toxicity: implications for research in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

The effects of acute or repeated cocaine administration on nerve terminal glutamate within the rat mesolimbic system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

The organization of the projection from the cerebral cortex to the striatum in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Haloperidol reverses the changes in striatal glutamatergic immunolabeling following a 6-OHDA lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Haloperidol-induced morphological changes in striatum are associated with glutamate synapses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Modulation of striatal [3H]-glutamic acid release by dopaminergic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor f

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Chronic L-dopa alters striatal NMDA receptors in rats with dopaminergic injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Techniques to optimize post-embedding single and double staining for amino acid neurotransmitters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Activation of dopamine receptors inhibits calcium-dependent glutamate release from cortico--striatal terminals in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Bilateral 6-hydroxydopamine-induced lesion of the nigrostriatal dopamine pathway reproduces the effects of unilateral lesion on substance P but not on enkephalin expression in rat basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Determination of amino acids in biological, pharmaceutical, plant and food samples by automated precolumn derivatization and high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Antiparkinsonian actions of glutamate antagonists--alone and with L-DOPA: a review of evidence and suggestions for possible mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Partial protective effect of MK-801 on MPTP-induced reduction of striatal dopamine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Glutamate is not involved in the MPP+-induced dopamine overflow in the striatum of freely moving C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Effects of haloperidol metabolites on neurotransmitter uptake and release: possible role in neurotoxicity and tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Glutamate receptor binding sites in MPTP-treated mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

Dopaminergic modulation of glutamate release in striatum as measured by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900050-X

10.1016/S0014-4886(02)00050-X

7 January 2021

Identifiers

DOI

1 reference

31 October 2017

1 reference